Global Patent Index - EP 0650369 A1

EP 0650369 A1 19950503 - A MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN FOR USE AS VACCINE AGAINST AN IMMUNODEFICIENCY VIRUS.

Title (en)

A MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN FOR USE AS VACCINE AGAINST AN IMMUNODEFICIENCY VIRUS.

Title (de)

EIN ANTIGEN DES HAUPTHISTOKOMPATIBILITÄTS-KOMPLEX ZUR VERWENDUNG ALS IMPFSTOFF GEGEN EINEN, DIE IMMUNSCHWÄCHE HERVORRUFENDEN VIRUS.

Title (fr)

ANTIGENE DU COMPLEXE MAJEUR D'HISTOCOMPATIBILITE UTILISE COMME VACCIN CONTRE UN VIRUS D'IMMUNO-DEFICIENCE.

Publication

EP 0650369 A1 19950503 (EN)

Application

EP 93916056 A 19930713

Priority

  • GB 9301459 W 19930713
  • GB 9214871 A 19920713

Abstract (en)

[origin: WO9401130A1] A major histocompatibility complex class I antigen is useful as a vaccine against an immunodeficiency virus. The antigen may be a human class I antigen such as an HLA-A, HLA-B or HLA-C antigen or (beta)2 microglobulin. The virus may be a human immunodeficiency virus (HIV) such as HIV-1 or HIV-2.

IPC 1-7

A61K 39/00

IPC 8 full level

A61K 39/00 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07K 14/74 (2006.01)

CPC (source: EP US)

A61P 31/12 (2018.01 - EP); A61P 31/18 (2018.01 - EP); C07K 14/70539 (2013.01 - EP); A61K 39/00 (2013.01 - EP US)

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9401130 A1 19940120; AU 4576293 A 19940131; CA 2140150 A1 19940120; EP 0650369 A1 19950503; GB 9214871 D0 19920826; JP H07508984 A 19951005

DOCDB simple family (application)

GB 9301459 W 19930713; AU 4576293 A 19930713; CA 2140150 A 19930713; EP 93916056 A 19930713; GB 9214871 A 19920713; JP 50313294 A 19930713